Personal tools

MCL coexpression mm9:3078: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0001016!1.46e-30!75;UBERON:0001017!1.01e-29!73;UBERON:0000073!1.50e-27!54;UBERON:0010314!6.30e-27!92;UBERON:0004121!9.68e-27!95;UBERON:0000924!9.68e-27!95;UBERON:0006601!9.68e-27!95;UBERON:0001049!2.28e-26!52;UBERON:0005068!2.28e-26!52;UBERON:0006241!2.28e-26!52;UBERON:0007135!2.28e-26!52;UBERON:0002346!8.06e-26!64;UBERON:0003075!8.06e-26!64;UBERON:0007284!8.06e-26!64;UBERON:0000955!2.17e-23!47;UBERON:0006238!2.17e-23!47;UBERON:0002616!6.85e-23!46;UBERON:0010371!2.63e-22!73;UBERON:0003080!8.68e-20!40;UBERON:0003056!1.99e-19!49;UBERON:0002780!4.62e-19!39;UBERON:0001890!4.62e-19!39;UBERON:0006240!4.62e-19!39;UBERON:0002020!4.80e-19!34;UBERON:0003528!1.57e-16!29;UBERON:0002791!1.57e-16!29;UBERON:0001893!1.57e-16!29;UBERON:0000956!7.95e-12!21;UBERON:0001869!7.95e-12!21;UBERON:0000203!7.95e-12!21;UBERON:0002619!5.02e-10!17;UBERON:0000025!3.20e-09!114;UBERON:0004111!1.42e-08!122;UBERON:0003076!4.27e-07!12;UBERON:0003057!4.27e-07!12;UBERON:0002021!5.09e-07!10;UBERON:0000411!5.09e-07!10;UBERON:0001950!5.09e-07!10
|ontology_enrichment_uberon=UBERON:0001016!1.46e-30!75;UBERON:0001017!1.01e-29!73;UBERON:0000073!1.50e-27!54;UBERON:0010314!6.30e-27!92;UBERON:0004121!9.68e-27!95;UBERON:0000924!9.68e-27!95;UBERON:0006601!9.68e-27!95;UBERON:0001049!2.28e-26!52;UBERON:0005068!2.28e-26!52;UBERON:0006241!2.28e-26!52;UBERON:0007135!2.28e-26!52;UBERON:0002346!8.06e-26!64;UBERON:0003075!8.06e-26!64;UBERON:0007284!8.06e-26!64;UBERON:0000955!2.17e-23!47;UBERON:0006238!2.17e-23!47;UBERON:0002616!6.85e-23!46;UBERON:0010371!2.63e-22!73;UBERON:0003080!8.68e-20!40;UBERON:0003056!1.99e-19!49;UBERON:0002780!4.62e-19!39;UBERON:0001890!4.62e-19!39;UBERON:0006240!4.62e-19!39;UBERON:0002020!4.80e-19!34;UBERON:0003528!1.57e-16!29;UBERON:0002791!1.57e-16!29;UBERON:0001893!1.57e-16!29;UBERON:0000956!7.95e-12!21;UBERON:0001869!7.95e-12!21;UBERON:0000203!7.95e-12!21;UBERON:0002619!5.02e-10!17;UBERON:0000025!3.20e-09!114;UBERON:0004111!1.42e-08!122;UBERON:0003076!4.27e-07!12;UBERON:0003057!4.27e-07!12;UBERON:0002021!5.09e-07!10;UBERON:0000411!5.09e-07!10;UBERON:0001950!5.09e-07!10
|tfbs_overrepresentation_for_novel_motifs=0.752782,0.564138,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,0.448066,0.328717,0.679146,0.275782,2.14745,0.585919,0.731217,0.963352,0.437236,0.841386,0.64294,1.7585,0.825437,1.24901,0.575271,0.411696,0.608816,0.872889,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.156582,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.371606,1.3966,1.41464,0.940919,0.657156,0.891887,0.425455,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,0.284975,1.44925,0.416814,1.03818,0.411601,1.04436,1.20986,0.684144,1.19917,1.16055,1.00151,0.459035,1.32978,0.181575,0.195254,0.99201,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,0.531443,0.509215,0.464141,1.26539,1.05692,0.352122,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,0.689894,0.681267,0.744607,1.38039,0.685481,0.876299,1.63327,0.580657,0.212464,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,1.79943,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.999018,0.721422,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,0.135528
}}
}}

Revision as of 22:22, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr17:21082371..21082472,+p1@Ppp2r1a
Mm9::chr19:7280751..7280791,-p1@Otub1
Mm9::chr6:124779416..124779470,-p1@Usp5


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0008234cysteine-type peptidase activity0.00970573685326965
GO:0006512ubiquitin cycle0.0388343598726612



Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
nervous system1.46e-3075
central nervous system1.01e-2973
regional part of nervous system1.50e-2754
structure with developmental contribution from neural crest6.30e-2792
ectoderm-derived structure9.68e-2795
ectoderm9.68e-2795
presumptive ectoderm9.68e-2795
neural tube2.28e-2652
neural rod2.28e-2652
future spinal cord2.28e-2652
neural keel2.28e-2652
neurectoderm8.06e-2664
neural plate8.06e-2664
presumptive neural plate8.06e-2664
brain2.17e-2347
future brain2.17e-2347
regional part of brain6.85e-2346
ecto-epithelium2.63e-2273
anterior neural tube8.68e-2040
pre-chordal neural plate1.99e-1949
regional part of forebrain4.62e-1939
forebrain4.62e-1939
future forebrain4.62e-1939
gray matter4.80e-1934
brain grey matter1.57e-1629
regional part of telencephalon1.57e-1629
telencephalon1.57e-1629
cerebral cortex7.95e-1221
cerebral hemisphere7.95e-1221
pallium7.95e-1221
regional part of cerebral cortex5.02e-1017
tube3.20e-09114
anatomical conduit1.42e-08122
posterior neural tube4.27e-0712
chordal neural plate4.27e-0712
occipital lobe5.09e-0710
visual cortex5.09e-0710
neocortex5.09e-0710


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}